DARZALEX 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
DARZALEX 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Pending
Register Number
1161101001IP
Prescription Type
Uso Hospitalario
Authorization Date
Jan 8, 2021
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1161101001IP
EMA Approved
Yes
Drug Classification
✗
Generic
No
✓
Orphan
Yes
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
DARATUMUMABActive
Quantity: 100 mg
Name: DARATUMUMAB
ATC CLASSIFICATION (3)
L01F
L01FC
L01FC01